📋 Tender Overview
Platform built in collaboration with Amazon Web Services, Modus Create to produce unmatched accuracy, efficiencies and compliance for life science companies
CHICAGO - 10 April, 2025 - , a leading provider of commercial services to the life sciences industry, today announced the next milestone in its journey to transform and innovate commercialization with the launch of , an AI-powered, industry-integrated platform that revolutionizes the Medical, Legal, and Regulatory (MLR) process.EVERSANA ORCHESTRATE MLR automates 90 percent of common tasks in the complex review process through a single platform thats easy to implement and complies with all regulatory requirements.The solution was built on Amazon Bedrock, which offers a choice of high-performing foundation models. EVERSANA worked with consulting firm , EVERSANAs Medical Affairs and Regulatory Affairs experts, and Veeva for seamless integration with EVERSANA ORCHESTRATE MLR is a game-changer for the life science industry, said Jim Lang, CEO. Through the power of AI and our collaborations with leading technology providers and in-house MLR experts, weve set a new standard for efficiency, compliance, and quality that is much needed in todays industry.Shifting the Industry MLR Process from Manual to AutomatedMost organizations have a manual MLR review process, requiring teams to comb through hundreds of marketing materials and cross-reference them with the most accurate regulatory claims information available. EVERSANA ORCHESTRATE MLR automatically identifies, extracts and manages claims in minutes with the power of AI.Additionally, annotation and cross-referencing for creative-type documents against claims data can now be completed in just a few clicks. Users will see all claims identified in the document and what needs to be updated and can make these updates in real-time, resulting in 90 percent faster content updates and an overall reduction in content reviews by as much as 50 percent.By harnessing the power of Amazon Bedrock, EVERSANA will empower life sciences companies with the AI tools they need to mitigate a significant pain point for the healthcare industry-- administrative burden. EVERSANA ORCHESTRATE MLR is just one example of how EVERSANA is using industry-leading AI solutions to solve some of healthcares most complex problems.Generative AI is transforming the life sciences industry by accelerating R&D, improving efficiency in manufacturing, and streamlining the path to commercialization, said Dan Sheeran, general manager, Healthcare and Life Sciences, AWS. The AI moment for life sciences is happening now, and our collaboration with EVERSANA demonstrates how AI technology is delivering solutions that not only solve long-standing industry challenges but also bring better therapies to patients faster.Improved Accuracy, Compliance & Quality in MLR Process The new solution, part of the EVERSANA ORCHESTRATE Operating System, is connected to EVERSANAs end-to-end commercialization services, ensuring all content is compliant, accurate, and efficiently reviewed. The platform has been proven to deliver precise, consistent, and high-quality materials for MLR review with an 86 percent reduction in submission errors. Through automation, it also is scalable and less resource intensive, resulting in an estimated 35 percent cost saving for most teams.EVERSANA ORCHESTRATE MLR has been piloted with several life science companies and the companys leading agency team at EVERSANA INTOUCH. To learn more about the platform, visit .About EVERSANAEVERSANA(r) is a leading independent provider of global services to the life sciences industry. The companys integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit or connect through and . Media ContactsMatt BraunVice President, Corporate Communications
